s-ethyl glutathione has been researched along with Injuries, Spinal Cord in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| del Rayo Garrido, M; Flores, A; Flores-Domínguez, C; García, E; Ibarra, A; Martiñón, S; Mestre, H; Morales, M; Silva-García, R | 1 |
| Espitia, A; Franco-Bourland, RE; Guízar-Sahagún, G; Ibarra, A; Madrazo, I; Martínez, A | 1 |
2 other study(ies) available for s-ethyl glutathione and Injuries, Spinal Cord
| Article | Year |
|---|---|
Therapeutic window for combination therapy of A91 peptide and glutathione allows delayed treatment after spinal cord injury.
Topics: Animals; Anterior Horn Cells; Cell Survival; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Female; Glutathione; Motor Activity; Myelin Basic Protein; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Time Factors; Time-to-Treatment | 2013 |
Glutathione monoethyl ester improves functional recovery, enhances neuron survival, and stabilizes spinal cord blood flow after spinal cord injury in rats.
Topics: Animals; Body Weight; Cell Survival; Glial Fibrillary Acidic Protein; Glutathione; Microcirculation; Movement; Neurons; Rats; Red Nucleus; Regional Blood Flow; Spinal Cord; Spinal Cord Injuries | 2005 |